Two of the three are currently out of favor, while the third is a mostly unknown name that's just become a timely prospect.

Dr Reddy's shares soar 3.54% after Alvotech partnership for Keytruda biosimilar, enhancing global reach in cancer ...

Morgan Stanley took a bullish stance on Eternal citing its leadership in both food delivery and quick commerce, efficient ...

U.S. stocks looked set to edge lower on Thursday as investors took some of their chips off the table ahead of crucial jobs data that will show how the labor market held up over months of tariff-fueled ...

LGLV provides defensive, low-volatility exposure in financials and industrials, suited for market uncertainty and policy ...

Wise Plc is planning to list its shares in the US, the latest blow to London’s stock market. While the fintech will maintain ...

Indian stock market witnessed a broad-based buying, which lifted Indian stock market benchmarks—the Sensex and the Nifty ...

Asian shares are trading mixed, as Wall Street's big recent rally lost some momentum following a pair of potentially ...

Palantir's Q1 2025 results confirm strong growth, rising margins, and scaling AI adoption. Find out why PLTR stock is a Buy.

Shares of Pony AI (NASDAQ: PONY) soared 112% in May, according to data from S&P Global Market Intelligence. The upstart is ...

Shares in Asia crept higher and the U.S. dollar languished ahead of the European Central Bank offering its policy outlook for ...

Tesla's high-profile leader, Elon Musk, has pushed the company into many lucrative verticals, everything from electric ...